FOI release

FOI reqeust for Remicade CTD 2.7.2 and 2.7.3 for CD and UC, Pediatric Phase 3

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00746

Received 10 July 2026

Published 18 September 2026

Request

I am writing to submit a Freedom of Information (FOI) request for the following document: * Remicade – CTD Sections 2.7.2 and 2.7.3 for Crohn's Disease (CD) and Ulcerative Colitis (UC), Pediatric Phase 3

Response

See attached

Documents

• Documents redacted to be released.zip (48.7 MB)
• FOI2026_00746 (redacted).pdf (777.1 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.